NEW YORK–(BUSINESS WIRE)– Ophthotech Corporation (Nasdaq:OPHT) today announced that it will report
its second quarter 2017 financial and operating results on Wednesday,
July 26, 2017. Following the announcement, Ophthotech’s management team
will host a live conference call and webcast at 8:00 a.m. Eastern Time
to discuss the Company’s financial results and provide a business update.
To participate in this conference call, dial 888-280-4443 (USA) or
719-457-2603 (International), passcode 8248330. A live, listen-only
audio webcast of the conference call can be accessed on the Investor
Relations section of the Ophthotech website at: www.ophthotech.com.
A replay will be available approximately two hours following the live
call for two weeks. The replay number is 888-203-1112 (USA Toll Free),
passcode 8248330.
About Ophthotech Corporation
Ophthotech is a biopharmaceutical company specializing in the
development of novel therapeutics for diseases of the eye. For more
information, please visit www.ophthotech.com.
Forward-looking Statements
Any statements in this press release about Ophthotech’s future
expectations, plans and prospects constitute forward-looking statements
for purposes of the safe harbor provisions under the Private Securities
Litigation Reform Act of 1995. Actual results may differ materially from
those indicated by such forward-looking statements as a result of
various important factors. Any forward-looking statements
represent Ophthotech’s views only as of the date of this press
release. Ophthotech anticipates that subsequent events and developments
will cause its views to change. While Ophthotech may elect to update
these forward-looking statements at some point in the
future, Ophthotech specifically disclaims any obligation to do so.
OPHT-G
View source version on businesswire.com: http://www.businesswire.com/news/home/20170721005076/en/
Contacts
Ophthotech Corporation
Investors
Kathy Galante,
212-845-8231
Vice President, Investor Relations and Corporate
Communications
kathy.galante@ophthotech.com
or
Media
SmithSolve
LLC on behalf of Ophthotech Corporation
Alex Van Rees, 973-442-1555
ext. 111
alex.vanrees@smithsolve.com
Source: Ophthotech Corporation
Cet article Ophthotech Corporation to Report Second Quarter 2017 Financial
Results and Host Conference Call on Wednesday, July 26, 2017 est apparu en premier sur EEI-BIOTECHFINANCES.